The total market capitalization of China’s publicly listed biotech firms has reached $1.5 trillion, second only to that of the United States. As China surges, many traditional American strengths have ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. IO Biotech ( (IOBT)) has shared an ...

From regulatory reforms to rewarding research and discoveries instead of patients treated, the existing ecosystem needs many changes to be future-ready Every headline about Donald Trump’s tariffs ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Genmab is continuing to build up its pipeline of wholly owned late-stage cancer assets, this time paying $8 billion for Netherlands-based Merus and its bispecific antibody. Analysts praised the ...

When it comes to Cyclerion Therapeutics' colorful backstory, the only consistency has been its inconsistency. Once upon a time, the Cambridge, Massachusetts-based company positioned itself as a ...

TXSE plans to open doors in 2026 and begin vying for new listings Dallas-based exchange hopes to reverse trend of diminishing ranks of public companies TXSE backers include BlackRock, Citadel ...

The trailer of the Huma Qureshi’s political-drama series, Maharani 4 was unveiled by the makers on Thursday. Directed by Puneet Sharma and created by Jolly LLB franchise director Subhash Kapoor, the ...

Millie, a California-based hybrid women’s health clinic, is expanding its offerings with perimenopause and menopause care. The offering, available in person and virtually, includes hormone therapy, ...

Despite possessing a solid data package on the potential of high-dose Sprinraza in spinal muscular atrophy (SMA), Biogen will now need to revise its application if it hopes to secure an FDA nod. The ...

"Cardiac Biotech Solutions, Inc. (CBSC) is a medical technology company dedicated to developing and commercializing advanced cardiac monitoring solutions. The Company’s flagship products, the MyCardia ...